These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease. Marconi S; Zwingers T Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1879-82. PubMed ID: 25010617 [TBL] [Abstract][Full Text] [Related]
8. Reexamination of the TEMPO Study. Shults CW Arch Neurol; 2005 Aug; 62(8):1320; author reply 1321. PubMed ID: 16087778 [No Abstract] [Full Text] [Related]
9. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease. Jost WH; Friede M; Schnitker J Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3349. PubMed ID: 25491607 [No Abstract] [Full Text] [Related]
10. [Rasagiline is not for all Parkinson disease patients: the ADAGIO study]. van Laar T; Boon AJ; Bloem BR Ned Tijdschr Geneeskd; 2010; 154():A2496. PubMed ID: 20977789 [TBL] [Abstract][Full Text] [Related]
11. [Rasagiline in motor fluctuations]. Miletzki A Fortschr Neurol Psychiatr; 2005 Sep; 73(9):488. PubMed ID: 16217881 [No Abstract] [Full Text] [Related]
12. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Guay DR Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539 [TBL] [Abstract][Full Text] [Related]
13. Monamine oxidase inhibitors: current and emerging agents for Parkinson disease. Fernandez HH; Chen JJ Clin Neuropharmacol; 2007; 30(3):150-68. PubMed ID: 17545750 [TBL] [Abstract][Full Text] [Related]
14. Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline. Degli Esposti L; Piccinni C; Sangiorgi D; Nobili F; Buda S Neurol Sci; 2016 Feb; 37(2):227-34. PubMed ID: 26474874 [TBL] [Abstract][Full Text] [Related]
15. [Rasagiline. A new monoamine oxidase b inhibitor for Parkinson treatment]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2005 Jul; 28(7):224-7. PubMed ID: 16038119 [No Abstract] [Full Text] [Related]
16. Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study. Peretz C; Segev H; Rozani V; Gurevich T; El-Ad B; Tsamir J; Giladi N Clin Neuropharmacol; 2016; 39(5):227-31. PubMed ID: 27438181 [TBL] [Abstract][Full Text] [Related]